Showing results (111-120 of 350) with videos related to

Sort By:
Pageof 35
Clinical Breast Cancer|September 29, 2023
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-AnalysisRaffaella D'Onofrio, Isabella Sperduti, Federico Piacentini, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 12, 2018
Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†Marco Chiappetta, Giovanni Leuzzi, Isabella Sperduti, et al.
Il Giornale Di Chirurgia|August 8, 2022
Surgical site infections in patients undergoing breast oncological surgery during the lockdown: An unexpected lesson from the COVID-19 pandemicSonia Cappelli, Diletta Corallino, Marco Clementi, et al.
BMC Cancer|June 7, 2022
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysisClaudia Omarini, Federico Piacentini, Isabella Sperduti, et al.
European Journal of Haematology|June 16, 2010
Baff serum level predicts time to first treatment in early chronic lymphocytic leukemiaStefano Molica, Giovanna Digiesi, Caterina Battaglia, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 18, 2010
Incidence of high chromogranin A serum levels in patients with non metastatic prostate adenocarcinomaMarialuisa Appetecchia, Aurela Meçule, Giuseppe Pasimeni, et al.
Journal of Gynecologic Oncology|May 13, 2016
Robotic single site versus robotic multiport hysterectomy in early endometrial cancer: a case control studyGiacomo Corrado, Giuseppe Cutillo, Emanuela Mancini, et al.
Clinical Lung Cancer|May 12, 2020
Mediastinal Up-Staging During Surgery in Non-Small-Cell Lung Cancer: Which Mediastinal Lymph Node Metastasis Patterns Better Predict The Outcome? A Multicenter AnalysisMarco Chiappetta, Giovanni Leuzzi, Isabella Sperduti, et al.
Anti-Cancer Drugs|February 12, 2009
Trastuzumab plus weekly epirubicin and paclitaxel for locally advanced and metastatic breast cancer: preliminary results of a feasibility-phase II study aimed at cardiotoxicityCecilia Nisticò, Emilio Bria, Vanja Vaccaro, et al.
Leukemia Research|November 4, 2011
Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL)Stefano Molica, Giovanna Digiesi, Anna Antenucci, et al.
Pageof 35